Raising the bar: can higher drug spending in the UK deliver for pharma and patients?
Following the creation of the UK’s National Institute for Health and Care Excellence (NICE) in 1999, a cost-effectiveness threshold of…
Analysis
Merck Wilmington Biotech Facility, Delaware, USA
Estonia’s digital health DNA: Trust, data, and biotech in focus
Psychedelics potential set to extend beyond mental health
Johnson & Johnson Biologics Manufacturing Facility, North Carolina, USA
Iovance Biotherapeutics Cell Therapy Center, Philadelphia, USA
Magazine: Cleanroom chronicles
From Nobel to next-gen: Sweden’s quiet life sciences ascent
